Justin Brogan

Justin Brogan is an associate in the firm’s Business Law department. He joined Goodwin in 2022.

Justin’s recent representations, among others, include:

Capital Markets and Mergers & Acquisitions:

• Klaviyo in its $659 million initial public offering
• HI-Bio in its up to $1.8 billion sale to Biogen 
• Ultimate.ai in its sale to Zendesk
• Veracode in its acquisition of Longbow Security
• Xcoding Labs in its sale to Datadog
• Verisma Systems in its acquisition of ScanSTAT Technologies
• Zynerba Pharmaceuticals in its $60 million sale to Harmony Biosciences
• RoadOne IntermodaLogistics in its sale to Ridgemont Equity Partners
• CVA USA in its acquisition of Cardiovascular Associates of Kissimmee

Private Financings:

• FamilyWell in its $4.25 million Series Seed financing
• Novo Holdings in its $40 million Series E investment in Cleveland Diagnostics
• Mantra Health in its $5 million Series A-1 financing
• LifeArc in its Convertible Note investment in Ozlo Sleep
• Bid Ventures in its SAFE financings 
• Aptihealth in its $50 million Series B financing
• Loom in its $40 million venture debt financing
• Positive Development in its $13 million venture debt financing

Justin is a member of the Boston Bar Association and Massachusetts LGBTQ Bar Association.

Justin joined the firm as a summer associate in 2021. Additionally, during his third year of law school, Justin worked as a law clerk in the firm’s Technology and Life Sciences groups.

During law school, Justin was the recipient of Goodwin’s Wayne A. Budd & Marian A. Tse Scholarship.